Several environmental factors, including infectious agents, have been suggested to cause Alzheimer’s disease (AD). Cytomegalovirus (CMV) has been associated with AD in several recent studies.
Objective:
To investigate whether carriage of CMV, alone or in combination with Herpes simplex virus (HSV), increased the risk of developing AD.
Methods:
Plasma samples from 360 AD cases (75.3% women, mean age 61.2 years), taken an average of 9.6 years before AD diagnosis, and 360 age-, sex-, cohort-, and sampling date matched dementia-free controls were analyzed to detect anti-CMV (immunoglobulin [Ig] G and IgM), group-specific anti-HSV (IgG and IgM), and specific anti-HSV1 and HSV2 IgG antibodies by enzyme-linked immunosorbent assays. AD cases and dementia-free controls were compared using conditional logistic regression analyses.
Results:
The presence of anti-CMV IgG antibodies did not increase the risk of AD (odds ratio [OR], 0.857; p = 0.497). Among AD cases, an association between CMV and HSV1 carriage was detected (OR 7.145, p < 0.001); in a conditional logistic regression model, the interaction between CMV and HSV1 was associated with AD development (OR 5.662; p = 0.007).
Conclusion:
The present findings do not support a direct relationship between CMV infection and the development of AD; however, an interaction between CMV and HSV1 was found to be associated significantly with AD development. These findings suggest that CMV infection facilitates the development of HSV1-associated AD, possibly via its effects on the immune system.
LetenneurL, PeresK, FleuryH, GarrigueI, Barberger-GateauP, HelmerC, OrgogozoJM, GauthierS, DartiguesJF (2008) Seropositivity to herpes simplex virus antibodies and risk of Alzheimer’s disease: A population-based cohort study. PLoS One3, e3637.
4.
LovheimH, GilthorpeJ, AdolfssonR, NilssonLG, ElghF (2015) Reactivated herpes simplex infection increases the risk of Alzheimer’s disease. Alzheimers Dement11, 593–599.
5.
LovheimH, GilthorpeJ, JohanssonA, ErikssonS, HallmansG, ElghF (2015) Herpes simplex infection and the risk of Alzheimer’s disease: A nested case-control study. Alzheimers Dement11, 587–592.
6.
KumarDK, ChoiSH, WashicoskyKJ, EimerWA, TuckerS, GhofraniJ, LefkowitzA, McCollG, GoldsteinLE, TanziRE, MoirRD (2016) Amyloid-beta peptide protects against microbial infection in mouse and worm models of Alzheimer’s disease. Sci Transl Med8, 340ra372.
7.
BourgadeK, GarneauH, GirouxG, Le PageAY, BoctiC, DupuisG, FrostEH, FulopTJr (2015) beta-Amyloid peptides display protective activity against the human Alzheimer’s disease-associated herpes simplex virus-1. Biogerontology16, 85–98.
8.
SosciaSJ, KirbyJE, WashicoskyKJ, TuckerSM, IngelssonM, HymanB, BurtonMA, GoldsteinLE, DuongS, TanziRE, MoirRD (2010) The Alzheimer’s disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS One5, e9505.
9.
WhiteMR, KandelR, TripathiS, CondonD, QiL, TaubenbergerJ, HartshornKL (2014) Alzheimer’s associated beta-amyloid protein inhibits influenza A virus and modulates viral interactions with phagocytes. PLoS One9, e101364.
10.
SantanaS, RecueroM, BullidoMJ, ValdiviesoF, AldudoJ (2012) Herpes simplex virus type I induces the accumulation of intracellular beta-amyloid in autophagic compartments and the inhibition of the non-amyloidogenic pathway in human neuroblastoma cells. Neurobiol Aging33, 430e419–433.
11.
MiklossyJ, KisA, RadenovicA, MillerL, ForroL, MartinsR, ReissK, DarbinianN, DarekarP, MihalyL, KhaliliK (2006) Beta-amyloid deposition and Alzheimer’s type changes induced by Borrelia spirochetes. Neurobiol Aging27, 228–236.
12.
LittleCS, JoyceTA, HammondCJ, MattaH, CahnD, AppeltDM, BalinBJ (2014) Detection of bacterial antigens and Alzheimer’s disease-like pathology in the central nervous system of BALB/c mice following intranasal infection with a laboratory isolate of Chlamydia pneumoniae. Front Aging Neurosci6, 304.
13.
BarnesLL, CapuanoAW, AielloAE, TurnerAD, YolkenRH, TorreyEF, BennettDA (2015) Cytomegalovirus infection and risk of Alzheimer disease in older black and white individuals. J Infect Dis211, 230–237.
14.
BuXL, YaoXQ, JiaoSS, ZengF, LiuYH, XiangY, LiangCR, WangQH, WangX, CaoHY, YiX, DengB, LiuCH, XuJ, ZhangLL, GaoCY, XuZQ, ZhangM, WangL, TanXL, XuX, ZhouHD, WangYJ (2015) A study on the association between infectious burden and Alzheimer’s disease. Eur J Neurol22, 1519–1525.
15.
CarboneI, LazzarottoT, IanniM, PorcelliniE, FortiP, MasliahE, GabrielliL, LicastroF (2014) Herpes virus in Alzheimer’s disease: Relation to progression of the disease. Neurobiol Aging35, 122–129.
16.
NimgaonkarVL, YolkenRH, WangT, Chung-ChouHC, McClainL, McDadeE, SnitzBE, GanguliM (2016) Temporal cognitive decline associated with exposure to infectious agents in a population-based, aging cohort. Alzheimer Dis Assoc Disord30, 216–222.
17.
AielloAE, HaanM, BlytheL, MooreK, GonzalezJM, JagustW (2006) The influence of latent viral infection on rate of cognitive decline over 4 years. J Am Geriatr Soc54, 1046–1054.
18.
StrandbergTE, PitkalaKH, LinnavuoriKH, TilvisRS (2003) Impact of viral and bacterial burden on cognitive impairment in elderly persons with cardiovascular diseases. Stroke34, 2126–2131.
19.
LurainNS, HansonBA, MartinsonJ, LeurgansSE, LandayAL, BennettDA, SchneiderJA (2013) Virological and immunological characteristics of human cytomegalovirus infection associated with Alzheimer disease. J Infect Dis208, 564–572.
20.
WestmanG, LidehallAK, MagnussonP, IngelssonM, KilanderL, LannfeltL, KorsgrenO, ErikssonBM (2013) Decreased proportion of cytomegalovirus specific CD8 T-cells but no signs of general immunosenescence in Alzheimer’s disease. PLoS One8, e77921.
21.
ItzhakiRF, KlapperP (2014) Cytomegalovirus: An improbable cause of Alzheimer disease. J Infect Dis209, 972–973.
22.
Soderberg-NauclerC, FornaraO, RahbarA (2016) Cytomegalovirus driven immunosenescence-An immune phenotype with or without clinical impact?Mech Ageing Dev158, 3–13.
23.
StoweRP, PeekMK, CutchinMP, GoodwinJS (2012) Reactivation of herpes simplex virus type 1 is associated with cytomegalovirus and age. J Med Virol84, 1797–1802.
24.
HallmansG, AgrenA, JohanssonG, JohanssonA, StegmayrB, JanssonJH, LindahlB, RolandssonO, SoderbergS, NilssonM, JohanssonI, WeinehallL (2003) Cardiovascular disease and diabetes in the Northern Sweden Health and Disease Study Cohort - evaluation of risk factors and their interactions. Scand J Public Health Suppl61, 18–24.
25.
American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision, American Psychiatric Association, Washington, DC.
26.
BoffettaP, BobakM, Borsch-SupanA, BrennerH, ErikssonS, GrodsteinF, JansenE, JenabM, JuergesH, KampmanE, KeeF, KuulasmaaK, ParkY, TjonnelandA, van DuijnC, WilsgaardT, WolkA, TrichopoulosD, BamiaC, TrichopoulouA (2014) The Consortium on Health and Ageing: Network of Cohorts in Europe and the United States (CHANCES) project–design, population and data harmonization of a large-scale, international study. Eur J Epidemiol29, 929–936.
27.
SjostromS, HjalmarsU, JutoP, WadellG, HallmansG, TjonnelandA, HalkjaerJ, ManjerJ, AlmquistM, MelinBS (2011) Human immunoglobulin G levels of viruses and associated glioma risk. Cancer Causes Control22, 1259–1266.
28.
AielloAE, NguyenHO, HaanMN (2008) C-reactive protein mediates the effect of apolipoprotein E on cytomegalovirus infection. J Infect Dis197, 34–41.
29.
BurgosJS, RamirezC, SastreI, ValdiviesoF (2007) Apolipoprotein E genotype influences vertical transmission of herpes simplex virus type 1 in a gender specific manner. Aging Cell6, 841–842.
